Mass spectrometry imaging with trapped ion mobility spectrometry (TIMS) facilitates spatially resolved chondroitin, dermatan and hyaluronan glycosaminoglycan (GAG) oligosaccharide analysis in situ.

22 April 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The spatial analysis of glycosaminoglycans (GAGs) by type and sulphation state is currently unobtainable. Here, we describe a mass spectrometry imaging (MSI) approach which enables the detection, identification, localisation and profiling of GAG oligosaccharides directly from retinal tissue. With in situ treatment of tissues with relevant chondroitinase enzymes, we liberate and spatially resolve chondroitin, dermatan and hyaluronan disaccharides through to hexasaccharides directly from tissue sections. We demonstrate, through the use of trapped ion mobility spectrometry (TIMS), that it is possible to both separate and semi-quantify isomeric GAG oligosaccharide ions across histologically relevant regions. Hence, we describe the first step towards the spatially resolved analysis of multiple GAGs and their oligosaccharide sulphation state(s) in tissues.

Keywords

glycosaminoglycan
mass spectrometry imaging
ion mobility spectrometry
glycomics
trapped ion mobility spectrometry

Supplementary materials

Title
Description
Actions
Title
Supplementary data: Mass spectrometry imaging with trapped ion mobility spectrometry (TIMS) facilitates spatially resolved chondroitin, dermatan and hyaluronan glycosaminoglycan (GAG) oligosaccharide analysis in situ.
Description
Tables of ions and their putative and fragment identification. Confirmation of workflows on extra samples and all ion images studied.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.